Spravato (Esketamine)

  • SPRAVATO® is the first FDA approved, esketamine nasal spray medication for adults with treatment-resistant depression (TRD). If you’ve struggled with depression and tried two or more antidepressants, SPRAVATO® may be right for you!

  • Landmark Health Systems we are thrilled to offer SPRAVATO® a groundbreaking therapy for patients with treatment-resistant depression. Administered as a nasal spray, esketamine works differently than conventional antidepressants, offering rapid relief by targeting specific brain receptors linked to mood regulation. Under the careful supervision of our experienced team, patients can benefit from this innovative approach, often seeing improvement in their symptoms within hours to days. We combine esketamine treatment with personalized care to help patients achieve lasting wellness.

  • We are located in Buffalo, NY

  • SPRAVATO® Certified REMS Center

  • To learn more about this medication and cost support, please click here.

  • If you are a current patient and will be starting Spravato treatment soon, we recommend reading this before your first treatment.

Spravato Nasal Spray Device

Interested in learning more? Give us a call at 716-462-0284 and press option 1!